ZYFARSA
RegisteredUS US · App #79307047 · Reg #6549793
Owned by
Glaxo Group LimitedApplication date
2021-01-08
Registration date
2021-11-09
Published date
2021-08-24
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
005006018044046051052
Current owners
Applicants
- Glaxo Group Limited
Previous owners
- Glaxo Group Limited
- Glaxo Group Limited
Correspondence
- [Legal Brand Protection, GSK]
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
1
Security: 0
Renewals
3
Prosecution events
18
Renewals & Maintenance
| Kind | Effective date | Status |
|---|---|---|
| Earliest Filing Date | 2026-11-09 | — |
| Latest Filing Date Without Additional Fee | 2027-11-09 | — |
| Latest Filing Date With Additional Fee | 2028-05-09 | — |
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2023-07-27 | CHANGE OF ADDRESS | GLAXO GROUP LIMITED → GLAXO GROUP LIMITED | Transfer |
Prosecution History
18 events| Date | Event |
|---|---|
| 2025-05-30 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2023-07-30 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 2022-03-20 | NOTIFICATION PROCESSED BY IB |
| 2022-02-25 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2022-02-25 | FINAL DISPOSITION PROCESSED |
| 2021-12-09 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| 2021-11-09 | REGISTERED-PRINCIPAL REGISTER |
| 2021-08-24 | PUBLISHED FOR OPPOSITION |
| 2021-08-22 | NOTIFICATION PROCESSED BY IB |
| 2021-08-04 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-08-04 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-08-04 | NOTICE OF PUBLICATION |
| 2021-07-20 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-07-19 | ASSIGNED TO EXAMINER |
| 2021-03-30 | APPLICATION FILING RECEIPT MAILED |
| 2021-03-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2021-03-25 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| 2021-03-18 | SN ASSIGNED FOR SECT 66A APPL FROM IB |